Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals
- PMID: 18991618
- PMCID: PMC4126611
- DOI: 10.2174/157016208786501463
Increased levels of human beta-defensins mRNA in sexually HIV-1 exposed but uninfected individuals
Abstract
Protection against HIV-1 infection in exposed seronegative (ESN) individuals likely involves natural resistance mechanisms that have not been fully elucidated. Human beta defensins (HBD) are antimicrobial peptides found primarily in mucosae, the main ports of HIV entry. HBD-2 and 3 mRNA are induced by HIV-1 in human oral epithelial cells and exhibit strong anti-HIV-1 activity; in addition, polymorphisms in the DEFB1 gene, which encodes HBD-1, have been associated with resistance/susceptibility to different infections, including HIV-1. Here, we have assessed the association of HBD expression with the ESN phenotype. Peripheral blood and vaginal/endocervical and oral mucosal samples were taken from 47 ESN, 44 seropositive (SP) and 39 healthy controls (HC). HBD-1, 2 and 3 mRNA copy numbers were quantified by real time RT-PCR and A692G/G1654A/A1836G polymorphisms in the DEFB1 gene were detected by restriction fragment length polymorphisms and confirmed by nucleotide sequencing. ESN expressed significantly greater mRNA copy numbers of HBD-2 and 3 in oral mucosa than HC; p=0.0002 and p=0.007, respectively. mRNA copy numbers of HBD-1, 2 and 3 in vaginal/endocervical mucosa from ESN and HC were similar. Homozygosity for the A692G polymorphism was significantly more frequent in ESN (0.39) than in SP (0.05) (p=0.0002). In summary, ESN exhibited enhanced mucosal expression of the innate defense genes HBD-2 and 3; however, additional studies are required to verify these results and the potential association of the A692G polymorphism to the relative resistance of ESN to HIV-1 infection.
Figures


Similar articles
-
Differential expression of human beta defensins in placenta and detection of allelic variants in the DEFB1 gene from HIV-1 positive mothers.Biomedica. 2011 Mar;31(1):44-54. doi: 10.1590/S0120-41572011000100007. Biomedica. 2011. PMID: 22159483
-
Loss of human beta-defensin 1, 2, and 3 expression in oral squamous cell carcinoma.Oral Microbiol Immunol. 2009 Oct;24(5):353-60. doi: 10.1111/j.1399-302X.2009.00512.x. Oral Microbiol Immunol. 2009. PMID: 19702947
-
High transcript levels of vitamin D receptor are correlated with higher mRNA expression of human beta defensins and IL-10 in mucosa of HIV-1-exposed seronegative individuals.PLoS One. 2013 Dec 5;8(12):e82717. doi: 10.1371/journal.pone.0082717. eCollection 2013. PLoS One. 2013. PMID: 24349345 Free PMC article.
-
Role of human beta-defensins in HIV infection.Adv Dent Res. 2006 Apr 1;19(1):42-8. doi: 10.1177/154407370601900109. Adv Dent Res. 2006. PMID: 16672548 Review.
-
[Enhancement of BCG-induced hBD-1 mRNA expression in human pulmonary gland epithelial cells].Hua Xi Yi Ke Da Xue Xue Bao. 2000 Sep;31(3):285-8. Hua Xi Yi Ke Da Xue Xue Bao. 2000. PMID: 12545809 Review. Chinese.
Cited by
-
Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix.J Reprod Immunol. 2011 Dec;92(1-2):8-20. doi: 10.1016/j.jri.2011.08.002. Epub 2011 Sep 22. J Reprod Immunol. 2011. PMID: 21943934 Free PMC article.
-
Role of Different Subpopulations of CD8+ T Cells during HIV Exposure and Infection.Front Immunol. 2017 Aug 7;8:936. doi: 10.3389/fimmu.2017.00936. eCollection 2017. Front Immunol. 2017. PMID: 28824656 Free PMC article. Review.
-
Luminal microvesicles uniquely influence translocating bacteria after SIV infection.Mucosal Immunol. 2021 Jul;14(4):937-948. doi: 10.1038/s41385-021-00393-8. Epub 2021 Mar 17. Mucosal Immunol. 2021. PMID: 33731830 Free PMC article.
-
Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells.Mol Cells. 2012 Apr;33(4):335-41. doi: 10.1007/s10059-012-2287-0. Epub 2012 Mar 23. Mol Cells. 2012. PMID: 22450687 Free PMC article.
-
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.PLoS One. 2010 Feb 25;5(2):e9436. doi: 10.1371/journal.pone.0009436. PLoS One. 2010. PMID: 20195543 Free PMC article.
References
-
- UNAIDS. Report on the global AIDS epidemic. Joint United Nations Programme on HIV/AIDS; Geneva: 2007. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive....
-
- Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today. 1996;17:21–4. - PubMed
-
- McMichael AJ, Rowland-Jones SL. Cellular immune responses to HIV. Nature. 2001;410:980–7. - PubMed
-
- Sierra S, Kupfer B, Kaiser R. Basics of the virology of HIV-1 and its replication. J Clin Virol. 2005;34:233–44. - PubMed
-
- Montoya CJ, Velilla PA, Chougnet C, Landay AL, Rugeles MT. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006;120(2):138–46. - PubMed